{"id":"ticagrelor-loading-dose","safety":{"commonSideEffects":[{"rate":"3-5","effect":"Bradycardia"},{"rate":"13-14","effect":"Dyspnea"},{"rate":"4-5","effect":"Bleeding (major)"},{"rate":"2-3","effect":"Ventricular pauses"},{"rate":"0.5-1","effect":"Hyperuricemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ticagrelor binds directly and reversibly to the P2Y12 adenosine diphosphate (ADP) receptor on platelets, inhibiting platelet activation and aggregation. The loading dose (typically 180 mg) rapidly achieves therapeutic platelet inhibition, reducing the risk of stent thrombosis and recurrent cardiovascular events in acute coronary syndrome patients. This mechanism is distinct from clopidogrel as ticagrelor does not require hepatic metabolism for activation.","oneSentence":"Ticagrelor is a P2Y12 platelet receptor antagonist that irreversibly blocks ADP-induced platelet aggregation to prevent thrombotic events.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:12:43.330Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome (ACS) for reduction of cardiovascular death, myocardial infarction, and stent thrombosis"},{"name":"Chronic coronary syndrome for secondary prevention of cardiovascular events"}]},"trialDetails":[{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT06228456","phase":"PHASE4","title":"Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-04-01","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT06853535","phase":"PHASE3","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-05-23","conditions":"Acute Ischemic Stroke, Clopidogrel Resistance","enrollment":5138},{"nctId":"NCT06591377","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-08-10","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT03869268","phase":"PHASE4","title":"The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2019-04-24","conditions":"Acute Coronary Syndrome","enrollment":72},{"nctId":"NCT06591338","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-09-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT04483583","phase":"PHASE4","title":"Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-12-08","conditions":"Coronary Artery Disease","enrollment":81},{"nctId":"NCT06318481","phase":"PHASE3","title":"TADCLOT- a Double Blind Randomized Controlled Trial","status":"COMPLETED","sponsor":"National Institute of Cardiovascular Diseases, Pakistan","startDate":"2024-02-19","conditions":"Stent Thrombosis, Myocardial Infarction, Acute","enrollment":2200},{"nctId":"NCT03357874","phase":"PHASE3","title":"TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2018-10-28","conditions":"Acute Coronary Syndrome","enrollment":259},{"nctId":"NCT03465644","phase":"PHASE4","title":"TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI","status":"COMPLETED","sponsor":"Duk-Woo Park, MD","startDate":"2019-02-12","conditions":"Coronary Stenoses","enrollment":2018},{"nctId":"NCT02733341","phase":"PHASE4","title":"The Effect of IV Cangrelor and Oral Ticagrelor Study","status":"COMPLETED","sponsor":"The Royal Wolverhampton Hospitals NHS Trust","startDate":"2016-07-21","conditions":"Acute Coronary Syndrome (ACS), High On-treatment Platelet Reactivity (HTPR), Microvascular Obstruction (MVO)","enrollment":100},{"nctId":"NCT06943586","phase":"NA","title":"Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-04-09","conditions":"Stroke, Transient Ischemic Attack (TIA)","enrollment":200},{"nctId":"NCT03551964","phase":"PHASE4","title":"Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2018-08-01","conditions":"Acute Myocardial Infarction, Cardiogenic Shock","enrollment":605},{"nctId":"NCT05329155","phase":"NA","title":"Early Administration of Heparin At FMC for PPCI of STEMI Patients","status":"COMPLETED","sponsor":"Renmin Hospital of Wuhan University","startDate":"2022-07-20","conditions":"STEMI, Primary PCI","enrollment":1145},{"nctId":"NCT06759272","phase":"PHASE4","title":"Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients","status":"NOT_YET_RECRUITING","sponsor":"Nur Hafizah Annezah binti Utuh","startDate":"2025-02","conditions":"Coronary Arterial Disease (CAD), ACS (Acute Coronary Syndrome), SCAD","enrollment":120},{"nctId":"NCT06584812","phase":"PHASE1","title":"Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects","status":"COMPLETED","sponsor":"Tianjin Institute of Pharmaceutical Research Co., Ltd","startDate":"2024-09-09","conditions":"Acute Coronary Syndrome, Ischemic Stroke","enrollment":14},{"nctId":"NCT03606642","phase":"PHASE2","title":"SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy","status":"TERMINATED","sponsor":"HonorHealth Research Institute","startDate":"2018-11-19","conditions":"Coronary Artery Disease, Atherosclerosis, Stent Placement","enrollment":50},{"nctId":"NCT03708588","phase":"PHASE4","title":"Chewed Versus Integral Pill of Ticagrelor","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2018-09-19","conditions":"Percutaneous Coronary Intervention","enrollment":112},{"nctId":"NCT06591390","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-02-09","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06591312","phase":"PHASE3","title":"Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT05117866","phase":"NA","title":"Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Meditrix Corp","startDate":"2020-09-15","conditions":"Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":307},{"nctId":"NCT06242145","phase":"PHASE3","title":"Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-01-01","conditions":"Ischemic Stroke","enrollment":580},{"nctId":"NCT06561867","phase":"PHASE3","title":"Ticagrelor Versus Cilostazol in Ischemic Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-08-30","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06196047","phase":"PHASE3","title":"Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2023-12-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT06202755","phase":"PHASE3","title":"Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-03-30","conditions":"Ischemic Stroke","enrollment":580},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06484647","phase":"","title":"Comparing T-stenting And Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation","status":"RECRUITING","sponsor":"San Luigi Gonzaga Hospital","startDate":"2024-06-01","conditions":"Coronary Artery Disease, Ischemic Heart Disease, Chronic Coronary Syndrome","enrollment":382},{"nctId":"NCT02016170","phase":"NA","title":"Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-03","conditions":"Coronary Artery Disease, Acute Coronary Syndrome","enrollment":82},{"nctId":"NCT05553613","phase":"PHASE3","title":"Ticagrelor Versus Clopidogrel in Ischemic Stroke","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-10-01","conditions":"Ischemic Stroke","enrollment":900},{"nctId":"NCT04122170","phase":"PHASE2","title":"Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old","status":"COMPLETED","sponsor":"SFJ Pharmaceuticals, Inc.","startDate":"2019-09-24","conditions":"Healthy","enrollment":207},{"nctId":"NCT06015477","phase":"NA","title":"Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-01-01","conditions":"Intracranial Aneurysm, Stent Complication","enrollment":180},{"nctId":"NCT06254391","phase":"PHASE2","title":"Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2023-07-03","conditions":"Myocardial Infarction, Acute Coronary Syndrome","enrollment":40},{"nctId":"NCT05209412","phase":"NA","title":"Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2022-02-01","conditions":"De Novo Stenosis, Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":370},{"nctId":"NCT06120725","phase":"PHASE3","title":"Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2021-09-01","conditions":"Ischemic Stroke","enrollment":580},{"nctId":"NCT04057300","phase":"PHASE4","title":"Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2018-10-01","conditions":"Acute Coronary Syndrome","enrollment":1038},{"nctId":"NCT05978791","phase":"","title":"Study on the Thrombolytic Effect of Platelet Membrane Coated Recombinant Staphylokinase on Human Arterial Thrombus","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-10-11","conditions":"Arterial Thrombosis","enrollment":24},{"nctId":"NCT05911659","phase":"","title":"Individualized and Combined Effects of Diabetes and Smoking on the Antiplatelet Activity of Ticagrelor in Acute Myocardial Infarction Patients Undergoing Primary PCI","status":"UNKNOWN","sponsor":"Mina Wageh Mohareb","startDate":"2023-05-01","conditions":"Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention","enrollment":60},{"nctId":"NCT04634162","phase":"PHASE4","title":"PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-02-09","conditions":"Coronary Artery Disease","enrollment":22},{"nctId":"NCT04944615","phase":"NA","title":"To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.","status":"RECRUITING","sponsor":"CCRF Inc., Beijing, China","startDate":"2022-10-21","conditions":"Chronic Total Occlusion of Coronary Artery","enrollment":1448},{"nctId":"NCT05779059","phase":"PHASE3","title":"Prasugrel Or Ticagrelor De-escalation in NSTE-ACS","status":"UNKNOWN","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2023-04-01","conditions":"Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), Unstable Angina","enrollment":50},{"nctId":"NCT04766437","phase":"PHASE2","title":"Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-02-19","conditions":"Non ST Segment Elevation Acute Coronary Syndrome","enrollment":75},{"nctId":"NCT01944800","phase":"PHASE4","title":"Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2013-09-15","conditions":"Acute Coronary Syndrome (ACS)","enrollment":4018},{"nctId":"NCT05474053","phase":"PHASE3","title":"Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-11-13","conditions":"Cardiovascular Diseases, Acute Coronary Syndrome","enrollment":29},{"nctId":"NCT02677545","phase":"PHASE2","title":"Ticagrelor Versus Clopidogrel in Carotid Artery Stenting","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2016-12","conditions":"Carotid Artery Stenosis","enrollment":210},{"nctId":"NCT04331145","phase":"PHASE4","title":"Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation","status":"COMPLETED","sponsor":"Andres Iñiguez Romo","startDate":"2020-06-23","conditions":"Symptomatic Aortic Stenosis","enrollment":40},{"nctId":"NCT05247385","phase":"PHASE4","title":"Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-03-20","conditions":"Coronary Artery Disease","enrollment":87},{"nctId":"NCT02817789","phase":"PHASE3","title":"Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2016-05-09","conditions":"Aortic Valve Stenosis","enrollment":50},{"nctId":"NCT04078737","phase":"PHASE3","title":"Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2019-09-23","conditions":"Stroke, Transient Ischemic Attack","enrollment":6412},{"nctId":"NCT03437044","phase":"PHASE4","title":"Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI","status":"COMPLETED","sponsor":"University of Florida","startDate":"2018-03-14","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease","enrollment":40},{"nctId":"NCT04695106","phase":"PHASE4","title":"Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2021-10-25","conditions":"Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome","enrollment":2230},{"nctId":"NCT04088123","phase":"","title":"Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects","status":"WITHDRAWN","sponsor":"George Washington University","startDate":"2020-04-01","conditions":"Thrombosis; Artery","enrollment":""},{"nctId":"NCT01846559","phase":"PHASE4","title":"The Antiplatelet and Immune Response Trial","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2013-04","conditions":"Healthy","enrollment":30},{"nctId":"NCT05045274","phase":"NA","title":"The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-12","conditions":"STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction","enrollment":300},{"nctId":"NCT03822377","phase":"PHASE3","title":"Ticagrelor Administered as Standard Tablet or Orodispersible Formulation","status":"COMPLETED","sponsor":"Azienda Ospedaliero Universitaria di Sassari","startDate":"2019-06-27","conditions":"ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI","enrollment":130},{"nctId":"NCT03884530","phase":"PHASE3","title":"Ticagrelol Versus Aspirin in Ischemic Stroke","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2019-05-01","conditions":"Acute Stroke, Ischemic Stroke","enrollment":169},{"nctId":"NCT02639143","phase":"PHASE4","title":"Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients","status":"COMPLETED","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2015-12","conditions":"Inflammation, Thrombosis","enrollment":50},{"nctId":"NCT04567290","phase":"PHASE4","title":"Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Centro Hospitalario La Concepcion","startDate":"2020-10-07","conditions":"Acute Coronary Syndrome","enrollment":50},{"nctId":"NCT04962451","phase":"PHASE4","title":"Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2017-09-01","conditions":"Cerebrovascular Accident, Cerebrovascular Accident, Acute","enrollment":13000},{"nctId":"NCT02989558","phase":"PHASE3","title":"A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI","status":"COMPLETED","sponsor":"University of Athens","startDate":"2016-12","conditions":"Aortic Valve Stenosis","enrollment":90},{"nctId":"NCT03533153","phase":"PHASE1, PHASE2","title":"Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2021-03-01","conditions":"Myocardial Infarction","enrollment":90},{"nctId":"NCT04754789","phase":"PHASE3","title":"Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-02-20","conditions":"ST Elevation Myocardial Infarction","enrollment":160},{"nctId":"NCT02931045","phase":"PHASE4","title":"Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2017-12-30","conditions":"Myocardial Infarction","enrollment":60},{"nctId":"NCT03354429","phase":"PHASE3","title":"THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-01-22","conditions":"Acute Ischaemic Stroke, Transient Ischaemic Attack","enrollment":11016},{"nctId":"NCT02618837","phase":"PHASE4","title":"Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2015-12-14","conditions":"Unstable Angina or Non ST Elevated Myocardial Infarction","enrollment":2520},{"nctId":"NCT02701140","phase":"PHASE2, PHASE3","title":"Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease","status":"COMPLETED","sponsor":"Italo Porto","startDate":"2016-06","conditions":"Myocardial Ischemia","enrollment":58},{"nctId":"NCT02617290","phase":"PHASE3","title":"Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-01-09","conditions":"Coronary Artery Disease, Myocardial Ischemia, Myocardial Infarction","enrollment":1900},{"nctId":"NCT03489863","phase":"PHASE4","title":"Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2018-05-30","conditions":"Coronary Artery Disease","enrollment":14},{"nctId":"NCT03247738","phase":"PHASE4","title":"Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI","status":"COMPLETED","sponsor":"University of Florida","startDate":"2017-11-20","conditions":"ST Segment Elevation Myocardial Infarction, Percutaneous Coronary Intervention","enrollment":50},{"nctId":"NCT04116931","phase":"PHASE4","title":"OPTImal Management of Antithrombotic Agents: OPTIMA-5","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2020-06-22","conditions":"Acute Coronary Syndrome (ACS)","enrollment":80},{"nctId":"NCT02944123","phase":"PHASE3","title":"Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2016-09","conditions":"Acute Coronary Syndrome","enrollment":120},{"nctId":"NCT02506140","phase":"PHASE2, PHASE3","title":"Platelet Reactivity in Acute Non-disabling Cerebrovascular Events","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2015-08","conditions":"Stroke, Ischemic Attack, Transient","enrollment":675},{"nctId":"NCT02531165","phase":"NA","title":"Platelet Inhibition After Pre-hospital Ticagrelor Using Fentanyl Compared to Morphine in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2015-09","conditions":"Acute Myocardial Infarction","enrollment":38},{"nctId":"NCT04431349","phase":"","title":"Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel","status":"COMPLETED","sponsor":"Ajou University School of Medicine","startDate":"2016-01-01","conditions":"Blood Loss, Surgical, Ticagrelor, Clopidogrel","enrollment":1097},{"nctId":"NCT02247128","phase":"PHASE4","title":"Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2014-01","conditions":"Aortic Valve Disease, Myocardial Infarction, Stroke","enrollment":1016},{"nctId":"NCT03039205","phase":"PHASE2","title":"Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-11-07","conditions":"Platelet Aggregation, Adenosine, Coronary Artery Disease","enrollment":90},{"nctId":"NCT02913469","phase":"PHASE4","title":"Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction","status":"UNKNOWN","sponsor":"General Hospital of Chinese Armed Police Forces","startDate":"2014-12-12","conditions":"ST-segment Elevation Myocardial Infarction","enrollment":128},{"nctId":"NCT03454841","phase":"","title":"Daily Variability of Platelet Aggregation in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor","status":"COMPLETED","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2018-02-26","conditions":"Acute Myocardial Infarction","enrollment":73},{"nctId":"NCT04267224","phase":"","title":"Early Versus Late Loading of Ticagrelol in Patients With STEMI","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-03-01","conditions":"Myocardial Infarction","enrollment":800},{"nctId":"NCT02376283","phase":"PHASE4","title":"P3AMI Antiplatelet Trial","status":"COMPLETED","sponsor":"The Royal Wolverhampton Hospitals NHS Trust","startDate":"2015-03-09","conditions":"Heart Attack","enrollment":87},{"nctId":"NCT02086903","phase":"PHASE3","title":"Clopidogrel And Ticagrelor in Healthy Subjects","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2014-02","conditions":"Pharmacodynamics","enrollment":12},{"nctId":"NCT04174261","phase":"PHASE4","title":"Ticagrelor in Remote Ischemic Preconditioning Study","status":"COMPLETED","sponsor":"Hellenic Society of Interventional Cardiology","startDate":"2017-01-29","conditions":"Periprocedural Myocardial Infarction","enrollment":245},{"nctId":"NCT02285751","phase":"PHASE2","title":"High \"on Treatment\" Platelet Reactivity in the Intensive Care Unit","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2012-11","conditions":"Critical Illness","enrollment":200},{"nctId":"NCT02071212","phase":"PHASE2","title":"Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.","status":"COMPLETED","sponsor":"Hellenic Cardiovascular Research Society","startDate":"2014-02","conditions":"Coronary Artery Disease","enrollment":120},{"nctId":"NCT02518464","phase":"PHASE4","title":"Ticagrelor Therapy for RefrACTORy Migraine Study","status":"COMPLETED","sponsor":"Columbia University","startDate":"2015-10","conditions":"Migraine, Headache, Migraine Headache","enrollment":40},{"nctId":"NCT02487732","phase":"PHASE4","title":"Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2015-07","conditions":"Acute Coronary Syndrome","enrollment":60},{"nctId":"NCT03111420","phase":"NA","title":"Study of AggreGuide A-100 (ADP) Assay","status":"COMPLETED","sponsor":"Aggredyne, Inc.","startDate":"2017-01-09","conditions":"Risk Factor, Cardiovascular, Platelet Dysfunction Due to Drugs","enrollment":280},{"nctId":"NCT02298088","phase":"PHASE3","title":"Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis","status":"COMPLETED","sponsor":"Hospital do Coracao","startDate":"2015-08","conditions":"Acute ST Segment Elevation Myocardial Infarction, Thrombolysis in Myocardial Infarction Flow","enrollment":3799},{"nctId":"NCT03613857","phase":"","title":"Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-15","conditions":"Myocardial Infarction","enrollment":1022},{"nctId":"NCT01587651","phase":"PHASE4","title":"Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2012-03","conditions":"Coronary Artery Disease","enrollment":110},{"nctId":"NCT02406248","phase":"PHASE4","title":"Brilinta Taiwan Post Approval Safety Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-04-23","conditions":"Non ST-elevation Myocardial Infarction","enrollment":108},{"nctId":"NCT01883869","phase":"PHASE1","title":"Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor","status":"COMPLETED","sponsor":"University of Kentucky","startDate":"2013-06","conditions":"Pneumonia, Community Acquired Pneumonia, Hospital Acquired Pneumonia","enrollment":60},{"nctId":"NCT03614832","phase":"PHASE4","title":"Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2018-05-01","conditions":"Platelet Reactivity","enrollment":100},{"nctId":"NCT01589978","phase":"PHASE4","title":"PROMUS Element Plus US Post-Approval Study","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2012-05","conditions":"Coronary Artery Disease","enrollment":2681},{"nctId":"NCT03062462","phase":"PHASE2, PHASE3","title":"Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2017-02-10","conditions":"Coronary Artery Disease, Clopidogrel, Poor Metabolism of","enrollment":80},{"nctId":"NCT02422888","phase":"PHASE4","title":"Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor","status":"UNKNOWN","sponsor":"Amsterdam UMC, location VUmc","startDate":"2015-05","conditions":"Myocardial Infarction","enrollment":110},{"nctId":"NCT02519608","phase":"PHASE2","title":"ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts","status":"COMPLETED","sponsor":"University Hospital of Ferrara","startDate":"2015-09","conditions":"Coronary Artery Disease, Chronic Obstructive Pulmonary Disease","enrollment":44},{"nctId":"NCT02428725","phase":"NA","title":"Platelet Reactivity Inhibition Following Ticagrelor Loading Dose and One Year Outcome","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2015-04","conditions":"Acute Coronary Syndrome","enrollment":640},{"nctId":"NCT02048085","phase":"PHASE4","title":"Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis","status":"WITHDRAWN","sponsor":"Medical Center of South Arkansas","startDate":"2014-01-02","conditions":"Acute ST Segment Elevation Myocardial Infarction, Acute Coronary Syndrome","enrollment":""},{"nctId":"NCT02943369","phase":"PHASE4","title":"Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI","status":"COMPLETED","sponsor":"Attikon Hospital","startDate":"2017-07-28","conditions":"STEMI","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Brilinta"],"phase":"marketed","status":"active","brandName":"Ticagrelor loading dose","genericName":"Ticagrelor loading dose","companyName":"Icahn School of Medicine at Mount Sinai","companyId":"icahn-school-of-medicine-at-mount-sinai","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ticagrelor is a P2Y12 platelet receptor antagonist that irreversibly blocks ADP-induced platelet aggregation to prevent thrombotic events. Used for Acute coronary syndrome (ACS) for reduction of cardiovascular death, myocardial infarction, and stent thrombosis, Chronic coronary syndrome for secondary prevention of cardiovascular events.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}